Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMJ Case Reports|February 23, 2021
Unusual cause of a painless soft tissue mass of the scalp: a rare presentation of primary intracranial neuroendocrine neoplasmSusruta Manivannan, Feras Sharouf, George Lammie, et al.Journal of Clinical Medicine|May 28, 2020
Dual-Task Effects on Performance of Gait and Balance in People with Knee Pain: A Systematic Scoping ReviewRula Abdallat, Feras Sharouf, Kate Button, et al.Seizure|April 6, 2019
Risk factors for the development of seizures after cranioplasty in patients that sustained traumatic brain injury: A systematic reviewRobert Spencer, Susruta Manivannan, Feras Sharouf, et al.British Journal of Neurosurgery|October 25, 2019
C-reactive protein kinetics post elective cranial surgery. A prospective observational studyFeras Sharouf, Rahim N Hussain, Sameera Hettipathirannahelage, et al.World Neurosurgery|March 2, 2020
Effect of Steroid Therapy on Risk of Subsequent Surgery for Neurologically Stable Chronic Subdural Hemorrhage-Retrospective Cohort Study and Literature ReviewCateno Concetto Tito Petralia, Susruta Manivannan, Dmitri Shastin, et al.Journal of Perioperative Practice|January 13, 2018
Analysis of neuro-theatre utilisation and reasons for cancellation to improve efficiency and productivityFeras Sharouf, Asfand Baig Mirza, Vazira Moosajee, et al.Journal of Neuroinflammation|September 22, 2021
IL-1β and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampusMalik Zaben, Niels Haan, Feras Sharouf, et al.Operative Neurosurgery (Hagerstown, Md.)|May 9, 2025
Endoscopic Implantation of Spinal Cord Stimulators: Technical Note and Comparison With Standard TechniquesAhmad M S Ali, Mohamed Elmolla, Vishwas Vijayendra, et al.Brain Sciences|October 24, 2020
Glycyrrhizin Blocks the Detrimental Effects of HMGB1 on Cortical Neurogenesis After Traumatic Neuronal InjurySusruta Manivannan, Balkis Harari, Maryam Muzaffar, et al.Brain Communications|February 5, 2021
Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's diseaseCheney J G Drew, Feras Sharouf, Elizabeth Randell, et al.Pageof 2